← All trials
NCT02489045
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 6, 2015
- Primary completion
- Mar 31, 2019
- Completion date
- Mar 31, 2019
- First posted
- Jul 2, 2015
- Last posted
- Aug 13, 2021
- Enrollment
- 178
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Thomas Jefferson UniversityLead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- University of PennsylvaniaCollaborator
- Thomas Jefferson UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.